Bicycle Therapeutics PLC (ADR) Live Stock Price Today, Share Analysis and Chart

Name: Bicycle Therapeutics Plc - ADR: Is Infosys Ltd. worth buying?
Item: Bicycle Therapeutics Plc - ADR
Rating: 1.32066675
Author: Trendlyne DVM scores

about

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural ge...

4.45 -0.22 (-4.71%)

Near 52W Low of $4.24

283.7K

XNAS Volume

XNAS 15 May, 2026 2:30 PM (EDT)

Not Eligible

Expensive Valuation

25.2 / 100

Technically Bearish

27.7 / 100

1Yr Price target upside is 172%

9 analysts

Bicycle Therapeutics PLC (ADR) Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Bicycle Therapeutics PLC (ADR) Live Stock Price Today, Share Analysis and Chart

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural ge...

Near 52W Low of $4.24

SWOT Analysis

Bicycle Therapeutics PLC (ADR) Live Price Chart